Pain relief for the removal of femoral sheath in interventional cardiology adult patients

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2008, Pages

  Wensley, Cynthia J ^a   Kent, Bridie ^b   McAleer, Mike B ^c   Price, Sue M ^d   Stewart, Jim T ^d  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b THE UNIVERSITY OF AUCKLAND   (New Zealand)

^c NORTH SHORE HOSPITAL   (New Zealand)

^d AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIOLYTIC AGENT; ATROPINE; FENTANYL; GLYCERYL TRINITRATE; LEVOBUPIVACAINE; LIDOCAINE; LOCAL ANESTHETIC AGENT; MIDAZOLAM; MORPHINE; OPIATE; PLACEBO;

ANALGESIA; ANESTHESIA INDUCTION; CLINICAL TRIAL; DATA EXTRACTION; DRUG EFFICACY; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; META ANALYSIS; NAUSEA AND VOMITING; PAIN; QUALITY CONTROL; REVIEW; SHEATH REMOVAL; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

EID: 55049140268     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006043.pub2     Document Type: Review

References (52)

1. Fulton 2000{published data only} * Fulton TR, Peet GI, McGrath MA, Hilton D, Smith RE, Sigurdsson AF, Forrest QG. Effects of three analgesic regimens on the perception of pain after removal of femoral artery sheaths. American Journal of Critical Care 2000;9(2):125-9.
2. Fulton 2000a{published data only} Fulton TR, Peet GI, McGrath MA, Hilton D, Smith RE, Sigurdsson AF, Forrest QG. Effects of three analgesic regimens on the perception of pain after removal of femoral artery sheaths. American Journal of Critical Care 2000;9(2):125-9.
3. Fulton 2000b{published data only} Fulton TR, Peet GI, McGrath MA, Hilton D, Smith RE, Sigurdsson AF, Forrest QG. Effects of three analgesic regimens on the perception of pain after removal of femoral artery sheaths. American Journal of Critical Care 2000;9(2):125-9.
4. Fulton 2000c{published data only} Fulton TR, Peet GI, McGrath MA, Hilton D, Smith RE, Sigurdsson AF, Forrest QG. Effects of three analgesic regimens on the perception of pain after removal of femoral artery sheaths. American Journal of Critical Care 2000;9(2):125-9.
5. Kiat Ang 2007{published and unpublished data} Kiat Ang C, Leung DY, Lo S, French JK, Juergens CP. Effect of local anesthesia and intravenous sedation on pain perception and vasovagal reactions during femoral arterial sheath removal after percutaneous coronary intervention. International Journal of Cardiology 2007;116 (3):321-6.
6. Timlin 2005{published and unpublished data} Timlin HM, Carnaffin SA, Starkey IR, Northridge DB, Leslie SJ. Randomized, controlled study of long-acting local anesthetic (levobupivacaine) in femoral artery sheath management during and after percutaneous coronary intervention.The Journal of Invasive Cardiology 2005;17(8):406-8.
7. Vish 2000b{published data only} Vish NA. Buffered lidocaine's effect on procedure complications, pain, movement, site outcome, and satisfaction with sheath removal in interventional cardiology patients. Digital Dissertations 2001.
8. Vish 2001{published data only} * Vish NA. Buffered lidocaine's effect on procedure complications, pain, movement, site outcome, and satisfaction with sheath removal in interventional cardiology patients. Digital Dissertations 2001.
9. Vish 2001a{published data only} Vish NA. Buffered lidocaine's effect on procedure complications, pain, movement, site outcome, and satisfaction with sheath removal in interventional cardiology patients. Digital Dissertations 2001.
10. Bowden 1995{published data only} Bowden SM, Worrey JA. Assessing patient comfort: local infiltration of lidocaine during femoral sheath removal. American Journal of Critical Care 1995;4(5):368-9.
11. Deane 2002{published data only (unpublished sought but not used)} Deane J. Assessing patient comfort: the use of IV Diazepam as conscious sedation during removal of femoral arterial sheaths following coronary angioplasty. (Project record). National Research Register http://www.nhs.uk 2002.
12. Lambert 1996{published data only} Lambert CR, Bikkina M, Shakoor A, Korzun WJ. New vascular sheath for subcutaneous drug administration: design, animal testing, and clinical application for pain prevention after angioplasty. Catheterization and Cardiovascular Diagnosis 1996;37(1):68-72.
13. Lambert 1997{published data only} Lambert CR, Bikkina M, Shakoor A, Korzun WJ. New sheath for vascular access and subcutaneous drug administration: multicenter clinical trial for pain prevention after cardiac catheterization. Catheterization and Cardiovascular Diagnosis 1997;40(1):81-3.
14. Wadas 1998{published data only} Wadas T, Hill J. Is lignocaine infiltration during sheath removal necessary?. Heart Lung 1998;27(1):31-6.
15. Cook 2007{unpublished data only} Randomized controlled trial examining the effect of subcutaneous xylocaine 2% on the incidence of vasovagal reactions and pain intensity during femoral artery sheath removal.. Ongoing study May 2007.
16. Achar 2002 Achar S, Kundu S. Principles of office anesthesia: part I. Infiltrative anesthesia. American Family Physician 2002;66(1):91-4.
17. Benson 2005 Benson LM, Wunderly D, Perry B, Kabboord J, Wenk T, Birdsall B, et al.Determining best practice: comparison of three methods of femoral sheath removal after cardiac interventional procedures. Heart and Lung 2005;34(2):115-21.
18. Berkun 2003 Berkun Y, Ben-Zvi A, Levy Y, Galili D, Shalit M. Evaluation of adverse reactions to local anesthetics: experience with 236 patients. Annals of Allergy, Asthma and Immunology 2003;91(4):342- 5.
19. Boss 1988 Boss BJ, Brewer L. Syncope: neuroscience nursing assessment based on an understanding of underlying pathophysiological mechanisms. Journal of Neuroscience Nursing 1988;20(4):245-52.
20. Botti 2000 Botti M. Report of the Australia and New Zealand survey of diagnostic and interventional cardiology practice. Sourced from Sanders K. The Alfred Hospital, Melbourne, Australia.
21. Chlan 2005 Chlan LL, Sabo J, Savik K. Effects of three groin compression methods on patient discomfort, distress, and vascular complications following a percutaneous coronary intervention procedure. Nursing Research 2005;54(6):391-8.
22. Collins 1997 Collins SL, Moore RA, McQuay HJ. The visual analogue pain intensity scale: what is moderate pain in millimetres?. Pain 1997;72: 95-97.
23. Davis 1997 Davis C, VanRiper S, Longstreet J, Moscucci M. Vascular complications of coronary intervention. Heart and Lung 1997;26(2):118-27.
24. Downie 1978 Downie WW, Leatham PA, Rhind VM, Wright V, Branco JA, Anderson JA. Studies with pain rating scales. Annals of the Rheumatic Diseases 1978;37(4):378-81.
25. Gall 1996 Gall H, Kaufman R, Kalveram CM. Adverse reactions to local anaesthetics: analysis of 197 cases. Jounal of Allergy and Clinical Immunology 1996;97(4):933-7.
26. Ilia 1997 Ilia R. Coronary occlusion post angioplasty associated with vasovagal reaction. Catheterization and Cardiovascular Diagnosis 1997; Vol. 3, issue 40:336.
27. Jadad 1996 Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds JM, Gavaghan DJ, McQuay HJ. Assessing the quality of reports on randomised clinical trials: Is blinding necessary?. Controlled Clinical Trials 1996;17:1-12.
28. Juni 2001 Juni P, Altman DG, Egger M. Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ 2001;323(7303): 42-6.
29. Kelly 1998 Kelly AM. Does the clinically significant difference in visual analog scale pain scores vary with gender, age, or cause of pain?. Academic Emergency Medicine 1998;5(11):1086-90.
30. Kendrick 2005 Kendrick DB, Strout TD. The minimum clinically significant difference in patient-assigned numeric scores for pain. American Journal of Emergency Medicine 2005;23(7):828-32.
31. Leslie 2006 Leslie S. personal communication April 28th 2006.
32. Levine 2003 Levine G, Kern M, Berger P, Brown D, Klein L, Kereiakes D, et al.Management of patients undergoing percutaneous coronary vascularisation. Annals of Internal Medicine 2003;139(2):123-36.
33. Macy 2003 Macy E. Local anesthetic adverse reaction evaluations: the role of the allergist. Annals of Allergy, Asthma and Immunology 2003;91(4): 319-20.
34. Mager 1994 Mager A, Strasberg B, Rechavia E, Birnbaum Y, Mazur A, Yativ N, Sclarovsky S. Clinical significance and predisposing factors to symptomatic bradycardia and hypotension after percutaneous transluminal coronary angioplasty. The American Journal of Cardiology 1994; 74:1085-8.
35. MIMS 2004 MIMS. MIMS New Ethicals. Auckland: Multimedia (NZ) LTD, 2004.
36. Mlekusch 2006 Mlekusch W, Dick P, Haumer M, Sabeti S, Minar E, Schillinger M. Arterial puncture site management after percutaneous transluminal procedures using a hemostatic wound dressing (Clo-Sur P.A.D.) versus conventional manual compression: a randomized controlled trial. Journal of Endovascular Therapy: Official Journal of the International Society of Endovascular Specialists 2006;13(1):23-31.
37. O'Grady 2002 O'Grady E. Removal of a femoral sheath following PTCA in cardiac patients. Professional Nurse 2002;17(11):651-4.
38. Peet 1995 Peet, GI, McGrath MA, Brunt JH, Hilton, JD. Femoral arterial sheath removal after PTCA: a cross Canada survey. Canadian Journal of Cardiovascular Nursing 1995;6(3-4):13-9. [MEDLINE: 8573276]
39. Plummer 2006 Plummer J. personal communication 24th February 2006.
40. Plummer 2006a Plummer J. personal communication April 18th 2006.
41. Puntillo 2001 Puntillo KA, White C, Morris AB, Perdue ST, Stanik-Hutt J, Thompson CL, Wild LR. Patients' perceptions and responses to procedural pain: results from thunder project II. American Journal of Critical Care 2001;10(4):238-51.
42. Rama 1997 Rama BN, Mohiuddin SM, Mooss AN, Khemani AK, Ryschon KL, Lucas BD, et al.Double-blind, randomized, placebo-controlled evaluation of atropine to prevent vasovagal reaction during removal of femoral arterial sheaths. Pharmacotherapy 1997;17(5):867-73.
43. Redelmeier 1996 Redelmeier DA, Kahneman D. Patients' memories of painful medical treatments: real-time and retrospective evaluations of two minimally invasive procedures. Pain 1996;66(1):3-8.
44. Rubin 1996 Rubin S, Wiens L, Fingler I, Sawyer T, Garcia-Vargas P, Stovicek Z. Evaluating a change in practice: femoral sheath removal by registered nurses. Canadian Journal of Cardiovascular Nursing 1996;7(3):19-27.
45. Sanders 2005 Sanders K. personal communication 12 May 2005.
46. Sauro 2005 Sauro MD, Greenberg RP. Endogenous opiates and the placebo effect: a meta-analytic review. Journal of Psychosomatic Research 2005; 58(2):115-20.
47. Schultz 1995 Schultz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273(5):408-12.
48. Schulz 2002 Schulz KF, Grimes DA. Blinding in randomised trials: hiding who got what. Lancet 2001;359(9307):696-700.
49. Singer 2001 Singer AJ, Kowalska A, Thode HC Jr. Ability of patients to accurately recall the severity of acute painful events. Academic Emergency Medicine 2001;8(3):292-5.
50. Smith 2001 Smith T, Labriola R. Developing best practice in arterial sheath removal for registered nurses. Journal of Nursing Care Quality 2001;16 (1):61-7.
51. Sweetman 2005 Sweetman SC. Martindale: the complete drug reference. 4th Edition. London: Pharmaceutical Press, 2005.
52. Vickers 2000 Vickers AJ, de Craen AJ. Why use placebos in clinical trials? A narrative review of the methodological literature. Journal of Clinical Epidemiology 2000;53(2):157-61.